Kapstone Financial Advisors LLC Bristol Myers Squibb CO Transaction History
Kapstone Financial Advisors LLC
- $201 Billion
- Q2 2025
A detailed history of Kapstone Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kapstone Financial Advisors LLC holds 7,171 shares of BMY stock, worth $329,364. This represents 0.17% of its overall portfolio holdings.
Number of Shares
7,171
Previous 7,473
4.04%
Holding current value
$329,364
Previous $456 Million
27.17%
% of portfolio
0.17%
Previous 0.26%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.58BCall Options Held
26.1MPut Options Held
23.8M-
Vanguard Group Inc Valley Forge, PA195MShares$8.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.96 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...